covid-19 Business Watch
WATCH: The week in review
Michael Avery takes a look at the performance of different sectors within the economy with his guest experts
It’s been an important week in the continued battle against Covid-19, with the Johnson & Johnson (J&J) vaccine facing a hurdle that appears to be nothing more than a storm in a teacup. On Friday, the second phase of the country’s vaccination strategy kicked off with electronic registration for over 60s.
It’s unclear, at this stage, whether the government’s decision to pause the J&J vaccine rollout will have a material impact given that it hasn’t even started yet. This while China’s GDP jumped a record 18.3% in the first quarter from a year earlier, official data showed on Friday, slower than the 19% forecast by economists in a Reuters poll, and following 6.5% growth in the fourth quarter of 2020...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.